Advancing regulatory variant effect prediction with AlphaGenome.
Avsec Ž, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, Bycroft C, Nicolaisen L, Arvaniti E, Pan J, Thomas R, Dutordoir V, Perino M, De S, Karollus A, Gayoso A, Sargeant T, Mottram A, Wong LH, Drotár P, Kosiorek A, Senior A, Tanburn R, Applebaum T, Basu S, Hassabis D, Kohli P. · 2026
Read Advancing regulatory variant effect prediction with AlphaGenome. by Avsec Ž, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, Bycroft C, Nicolaisen L, Arvaniti E, Pan J, Thomas R, Dutordoir V, Perino M, De S, Karollus A, Gayoso A, Sargeant T, Mottram A, Wong LH, Drotár P, Kosiorek A, Senior A, Tanburn R, Applebaum T, Basu S, Hassabis D, Kohli P. (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc12851941.txt.
Introduction
Avsec and co-authors presented AlphaGenome, a DNA prediction model, in 2026. Earlier models traded sequence length against prediction detail. Each covered only some types of genomic measurement. AlphaGenome takes one million base pairs as input at once.
It predicts thousands of functional tracks at single-base resolution. Outputs span gene expression, chromatin access, and binding maps. Splice site usage and strength are also predicted. Trained on human and mouse genomes, it won 25 of 26 variant tests. It also reproduced known variant mechanisms near the TAL1 cancer gene. Trained tracks include splice sites and contact maps.
Catalog record
| CREATOR | Avsec Ž, Latysheva N, Cheng J, Novati G, Taylor KR, Ward T, Bycroft C, Nicolaisen L, Arvaniti E, Pan J, Thomas R, Dutordoir V, Perino M, De S, Karollus A, Gayoso A, Sargeant T, Mottram A, Wong LH, Drotár P, Kosiorek A, Senior A, Tanburn R, Applebaum T, Basu S, Hassabis D, Kohli P. |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 100 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Advancing regulatory variant effect prediction with AlphaGenome By Žiga Avsec, Natasha Latysheva, Jun Cheng, Guido Novati, Kyle R Taylor, Tom Ward, Clare Bycroft, Lauren Nicolaisen, Eirini Arvaniti, Joshua Pan, Raina Thomas, Vincent Dutordoir Published in: Nature DOI: 10.1038/s41586-025-10014-0 ABSTRACT Abstract Deep learning models that predict functional genomic measurements from DNA sequences are powerful tools for deciphering the genetic regulatory code. Existing methods involve a trade-off between input sequence length and prediction resolution, thereby limiting their modality scope and performance1–5. We present AlphaGenome, a unified DNA sequence model, which takes as input 1 Mb of DNA sequence and predicts thousands of functional genomic tracks up to single-base-pair resolution across diverse modalities. The modalities include gene expression, transcription initiation, chromatin accessibility, histone modifications, transcription factor binding, chromatin contact maps, splice site usage and splice junction coordinates and strength. Trained on human and mouse genomes, AlphaGenome matches or exceeds the strongest available external models in 25 of 26 evaluations of variant effect prediction. The ability of AlphaGenome to simultaneously score variant effects across all modalities accurately recapitulates the mechanisms of clinically relevant variants near the TAL1 oncogene6. To facilitate broader use, we provide tools for making genome track and variant effect predictions from sequence. Subject terms: Machine learning, Genome informatics MAIN Interpreting the impact of genome sequence variation remains a central biological challenge. Non-coding variants, which reside outside of protein-coding regions, are particularly challenging to interpret because of the diverse molecular consequences they can elicit. For example, non-coding variants can modulate genome properties such as chromatin accessibility, epigenetic modifications and three-dimensional chromatin conformation. Variants can further influence messenger RNA (mRNA) availability by altering expression levels or modifying sequence composition through splicing changes. Additionally, variants can exhibit cell-type-specific or tissue-specific effects. Given that more than 98% of observed genetic variation in humans is non-coding7, global characterization of the complex effects of this vast majority of variants remains intractable without computational predictions. Computational methods can learn patterns from experimental data to predict and explain variant effects. One class of methods,sequence-to-function models1–5, takes a DNA sequence as input and predicts genome tracks, a data format associating each DNA base pair with a value (representing read coverage, count or signal) derived from experimental assays performed in cell lines or tissues. Genome tracks span various data modalities measuring gene expression (with output types comprising RNA sequencing (RNA-seq), cap analysis of gene expression (CAGE) sequencing, and precision nuclear run-on analysis of capped RNA (PRO-cap)), splicing (splice sites, splice site usage and splice junctions), DNA accessibility (DNase I hypersensitive site sequencing (DNase-seq)) and assay for transposase-accessible chromatin sequencing (ATAC-seq)), histone modification (chromatin immunoprecipitation sequencing (ChIP-seq)), transcription factor binding or chromatin conformation (high-throughput chromosome (Hi-C) or micrococcal nuclease-based (Micro-C) conformation capture). Successfully trained sequence-to-function models accurately predict experimental measurements from input sequences. Furthermore, by comparing genome track predictions from an alternative sequence versus a reference sequence, these models can predict the molecular effects of variants. Currently, deep learning-based sequence-to-function models face two fundamental trade-offs constraining their ability to predict how variants affect diverse modes of biological regulation. First, often owing to computational limitations, models must trade off between capturing long-range genomic interactions and achieving nucleotide-level predictive resolution. Although models such as SpliceAI4, BPNet8 and ProCapNet9 provide base-resolution predictions, they are restricted to short input sequences (for example, 10 kb or less), and thus may miss the influence of distal regulatory elements. Models such as Enformer1 and Borzoi2 can process longer sequences (approximately 200–500 kb) to capture broader context but at the cost of reducing output resolution (128-bp or 32-bp bins), which can blur fine-scale regulatory features such as splice sites, transcription factor footprints or polyadenylation sites. A second trade-off exists between capturing diverse modalities versus specializing in one or a few. Several state-of-the-art (SOTA) models are highly specialized for single modalities, such as SpliceAI4 for splice site prediction, ChromBPNet10 for local chromatin accessibility and Orca3 for three-dimensional genome architecture. However, specialized models alone are insufficient for capturing the diverse molecular consequences of variants across modalities. Even within a single modality like splicing, specialized models such as SpliceAI4 or Pangolin11 predict certain aspects (such as splice site prediction) while omitting others (such as splice junction prediction or competition between splice sites). Models like DeepSEA, Basenji, Enformer, Sei and Borzoi have demonstrated the utility and practicality of multimodal models. They allow users to use a single model for several modalities, instead of requiring several specialized models. Furthermore, their learned general sequence representation enables them to be readily fine-tuned for new tasks. However, these more generalist models can lag behind their specialized counterparts on certain tasks, such as splicing, or may lack particular modalities, such as contact maps. Here we present AlphaGenome, a model that unifies multimodal prediction, long-sequence context and base-pair resolution into a single framework. The model takes 1 Mb of DNA sequence as input and predicts a diverse range of genome tracks across numerous cell types. The splicing predictions of AlphaGenome include a new splice junction prediction approach alongside splice site usage prediction. We evaluated the performance of AlphaGenome using a comprehensive set of benchmarks, covering both its ability to accurately predict genome tracks on previously unseen DNA sequences and its effectiveness in variant effect prediction tasks. AlphaGenome achieved SOTA performance on 22 of 24 genome track prediction tasks and 25 of 26 variant effect prediction tasks. We performed extensive ablations of target resolution, sequence length, distillation and modality combinations to explain the performance of AlphaGenome and inform design choices for future sequence-to-function models. We envisage that AlphaGenome will provide a powerful and extensible foundation for analysing the regulatory code within the genome. We first present key technical details of the AlphaGenome data and training procedure, alongside a high-level summary of our evaluations (Fig. 1). We then demonstrate high-fidelity genome track prediction performance, a prerequisite for variant effect prediction (Fig. 2). Next, we focus on variant effect prediction with modality-specific deep dives into splicing (Fig. 3), gene expression (Fig. 4) and chromatin accessibility (Fig. 5). Finally, we highlight the model’s utility in cross-modality variant interpretation (Fig. 6) and dissect the impact of modelling choices on the performance of AlphaGenome (Fig. 7). [Figure: AlphaGenome model architecture, training regimes and comprehensive evaluation performance.a, Model overview. AlphaGenome processes 1 Mb of DNA sequences and species identity (human/mouse) to predict 5,930 human or 1,128 mouse genome tracks across diverse cell types and 11 output types at specific resolutions (far right). Computation leverages sequence parallelism, breaking the 1 Mb of DNA sequence into 131-kb chunks processed across devices. The core architecture features a U-Net-style design comprising an encoder (downsampling the sequence), transformers with inter-device communication and a decoder (upsampling), which feed into task-specific output heads at their respective resolutions (detailed in Extended Data Fig. 1). b, The pretraining process, in which 1-Mb DNA intervals are sampled from cross-validation folds, augmented (shifted and reverse complemented) and used to train the model against experimental targets, yields fold-specific and all-fold teacher models. c, The distillation process, in which a student model learns to reproduce predictions from frozen all-fold teacher models using augmented and mutationally perturbed input sequences, yields a single model suitable for variant effect prediction. d, Track prediction: pretrained fold-split model. Relative performance improvement (%) of AlphaGenome over